The effectiveness of propranolol in treating infantile haemangiomas: A meta-analysis including 35 studies

British Journal of Clinical Pharmacology

Volumn 78, Issue 1, 2014, Pages 44-57

  Lou, Yin ^a   Peng, Wen Jia ^a   Cao, Yi ^a   Cao, Dong Sheng ^a   Xie, Juan ^a   Li, Hong Hong ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

effectiveness; infantile haemangiomas; meta analysis; propranolol

Indexed keywords

PROPRANOLOL; STEROID; VINCRISTINE; ANTINEOPLASTIC AGENT;

BRADYCARDIA; BRONCHOSPASM; CAPILLARY HEMANGIOMA; CHILD; COCHRANE LIBRARY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CUSHINGOID SYNDROME; CUTANEOUS INFANTILE HEMANGIOMA; DATA BASE; DRUG EFFICACY; FATIGUE; FOLLOW UP; GASTROINTESTINAL REFLUX; GASTROINTESTINAL SYMPTOM; GROWTH RETARDATION; HUMAN; HYPERTENSION; HYPOGLYCEMIA; HYPOTENSION; INFANT; INFANTILE AIRWAY HAEMANGIOMA; INFANTILE HEPATIC HEMANGIOMA; LIVER HEMANGIOMA; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MEDLINE; META ANALYSIS; META ANALYSIS (TOPIC); PERIOCULAR INFANTILE HEMANGIOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; RISK; HEMANGIOMA; VASCULARIZATION;

ANTINEOPLASTIC AGENTS; HEMANGIOMA; HUMANS; INFANT; PROPRANOLOL;

EID: 84894192018     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12235     Document Type: Review

References (61)

1. Boye E, Jinnin M, Olsen BR,. Infantile hemangioma:challenges, new insights, and therapeutic promise. J Craniofac Surg 2009; 20: 678-684.
2. Maguiness SM, Frieden IJ,. Vascular birthmarks: tumors and malformations. In: Pediatric Dermatology, Vol. 2, 4th edn. eds, Schachner LA, Hansen RC,. Philadelphia, PA: Mosby Elsevier, 2011; 1135-1153.
3. Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, Lucky AW, Mancini AJ, Metry DW, Newell B, Nopper AJ, Frieden IJ,. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006; 118: 882-887.
4. Buckmiller L, Dyamenahalli U, Richter GT,. Propranolol for airway hemangiomas: case report of novel treatment. Laryngoscope 2009; 119: 2051-2054.
5. Perkins JA, Oliaei S, Garrison MM, Manning SC,. Airway procedures and hemangiomas: treatment patterns and outcome in U.S. pediatric hospitals. Int J Pediatr Otorhinolaryngol 2009; 73: 1302-1307.
6. Perkins JA, Duke W, Chen E, Manning S,. Emerging concepts in airway infantile hemangioma assessment and management. Otolaryngol Head Neck Surg 2009; 141: 207-212.
7. Nguyen J, Fay A,. Pharmacological therapy for periocular infantile haemangiomas: a review of the literature. Semin Ophthalmol 2009; 24: 178-184.
8. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A,. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-2651.
9. Durr ML, Meyer AK, Huoh KC, Frieden IJ, Rosbe KW,. Airway hemangiomas in PHACE syndrome. Laryngoscope 2012; 122: 2323-2329.
10. Moss HB, Sines DT, Blatt J, Dutton JJ, Proia AD,. Epithelioid hemangioma responsive to oral propranolol. Ophthal Plast Reconstr Surg 2012; 28: e88-90.
11. Mazereeuw-Hautier J, Hoeger PH, Benlahrech S, Ammour A, Broue P, Vial J, Ohanessian G, Léauté-Labrèze C, Labenne M, Vabres P, Rössler J, Bodemer C,. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. J Pediatr 2010; 157: 340-342.
12. Celik A, Tiryaki S, Musayev A, Kismali E, Levent E, Ergun O,. Propranolol as the first-line therapy for infantile hemangiomas: preliminary results of two centers. J Drugs Dermatol 2012; 11: 808-811.
13. Menezes MD, McCarter R, Greene EA, Bauman NM,. Status of propranolol for treatment of infantile hemangioma and description of a randomized clinical trial. Ann Otol Rhinol Laryngol 2011; 120: 686-695.
14. Greene AK,. Systemic corticosteroid is effective and safe treatment for problematic infantile hemangioma. Pediatr Dermatol 2010; 27: 322-323.
15. Peridis S, Pilgrim G, Athanasopoulos I, Parpounas K,. A meta-analysis on the effectiveness of propranolol for the treatment of infantile airway haemangiomas. Int J Pediatr Otorhinolaryngol 2011; 75: 455-460.
16. Cochran WG,. The combination of estimates from different experiments. Biometrics 1954; 10: 101-102.
17. Higgins JP, Thompson SE,. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
18. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
19. Mantel N, Haenszel W,. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
20. Begg CB, Mazumdar M,. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
21. Egger M, Davey SG, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
22. Harikrishna B, Ganesh A, Al-Zuahibi S, Al-Jabri S, Al-Waily A, Al-Riyami A, Al-Azri F, Masoud F, Al-Mujaini A,. Oral propranolol for the treatment of periorbital infantile hemangioma: a preliminary report from Oman. Middle East Afr J Ophthalmol 2011; 18: 298-303.
23. Manunza F, Syed S, Laguda B, Linward J, Kennedy H, Gholam K, Glover M, Giardini A, Harper JI,. Propranolol for complicated infantile haemangiomas: a case series of 30 infants. Br J Dermatol 2010; 162: 466-468.
24. Solomon T, Ninnis J, Deming D, Merritt TA, Hopper A,. Use of propranolol for treatment of hemangiomas in PHACE syndrome. J Perinatol 2011; 31: 739-741.
25. Corapcioǧlu F, Büyükkapu-Bay S, Binnetoǧlu K, Babaoǧlu A, Anik Y, Tugay M,. Preliminary results of propranolol treatment for patients with infantile hemangioma. Turk J Pediatr 2011; 53: 137-141.
26. Ghosh PS, Ghosh D,. Infantile intraspinal and extensive cutaneous hemangiomas: excellent response to propranolol. Neurology 2011; 76: 1771.
27. Fuchsmann C, Quintal MC, Giguere C, Ayari-Khalfallah S, Guibaud L, Powell J, McCone C, Froehlich P,. Propranolol as first-line treatment of head and neck hemangiomas. Arch Otolaryngol Head Neck Surg 2011; 137: 471-478.
28. Sarialioglu F, Erbay A, Demir S,. Response of infantile hepatic hemangioma to propranolol resistant to high-dose methylprednisolone and interferon-α therapy. Pediatr Blood Cancer 2010; 55: 1433-1434.
29. Breur JM, de Graaf M, Breugem CC, Pasmans SG,. Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report. Pediatr Dermatol 2011; 28: 169-171.
30. Rosbe KW, Suh KY, Meyer AK, Maguiness SM, Frieden IJ,. Propranolol in the management of airway infantile hemangiomas. Arch Otolaryngol Head Neck Surg 2010; 136: 658-665.
31. Mistry N, Tzifa K,. Use of propranolol to treat multicentric airway haemangioma. J Laryngol Otol 2010; 124: 1329-1332.
32. Truong MT, Chang KW, Berk DR, Heerema-McKenney A, Bruckner AL,. Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma. J Pediatr 2010; 156: 335-338.
33. Maturo S, Hartnick C,. Initial experience using propranolol as the sole treatment for infantile airway hemangiomas. Int J Pediatr Otorhinolaryngol 2010; 74: 323-325.
34. Raol N, Metry D, Edmonds J, Chandy B, Sulek M, Larrier D,. Propranolol for the treatment of subglottic hemangiomas. Int J Pediatr Otorhinolaryngol 2011; 75: 1510-1514.
35. Javia LR, Zur KB, Jacobs IN,. Evolving treatments in the management of laryngotracheal hemangiomas: will propranolol supplant steroids and surgery? Int J Pediatr Otorhinolaryngol 2011; 75: 1450-1454.
36. Yeh I, Bruckner AL, Sanchez R, Jeng MR, Newell BD, Frieden IJ,. Diffuse infantile hepatic hemangiomas: a report of four cases successfully managed with medical therapy. Pediatr Dermatol 2011; 28: 267-275.
37. Taban M, Goldberg RA,. Propranolol for orbital hemangioma. Ophthalmology 2010; 117: 195.
38. Cheng JF, Gole GA, Sullivan TJ,. Propranolol in the management of periorbital infantile haemangioma. Clin Experiment Ophthalmol 2010; 38: 547-553.
39. Marsciani A, Pericoli R, Alaggio R, Brisigotti M, Vergine G,. Massive response of severe infantile hepatic hemangioma to propanolol. Pediatr Blood Cancer 2010; 54: 176.
40. Denoyelle F, Leboulanger N, Enjolras O, Harris R, Roger G, Garabedian EN,. Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol 2009; 73: 1168-1172.
41. Blanchet C, Nicollas R, Bigorre M, Amedro P, Mondain M,. Management of infantile subglottic hemangioma: acebutolol or propranolol. Int J Pediatr Otorhinolaryngol 2010; 74: 959-961.
42. Theletsane T, Redfern A, Raynham O, Harris T, Prose NS, Khumalo NP,. Life-threatening infantile haemangioma: a dramatic response to propranolol. J Eur Acad Dermatol Venereol 2009; 23: 1465-1466.
43. Sans V, de la Roque ED, Berge J, Grenier N, Boralevi F, Mazereeuw-Hautier J, Lipsker D, Dupuis E, Ezzedine K, Vergnes P, Taïeb A, Léauté-Labrèze C,. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009; 124: e423-431.
44. Jephson CG, Manunza F, Syed S, Mills NA, Harper J, Hartley BE,. Successful treatment of isolated subglottic haemangioma with propranolol alone. Int J Pediatr Otorhinolaryngol 2009; 73: 1821-1823.
45. Price CJ, Lattouf C, Baum B, McLeod M, Schachner LA, Duarte AM, Connelly EA,. Propranolol vs corticosteroids for infantile hemangiomas. Arch Dermatol 2011; 147: 1371-1376.
46. Bertrand J, McCuaig C, Dubois J, Hatami A, Ondrejchak S, Powell J,. Propranolol versus prednisone in the treatment of infantile hemangiomas: a retrospective comparative study. Pediatr Dermatol 2011; 28: 649-654.
47. Jin YJ, Jin ZH, Cui XY, Jin YJ,. The clinical observation of propranolol taken orally for infantile hemangiomas. Chin J Dermatovenereol 2011; 25: 688-690.
48. Xiong S, Luo J, Zhou LJ, Wang XL, Tao LJ, Yang HL,. Application of propranolol in ocular hemangioma of infant. Int J Ophthalmol 2012; 12: 157-158.
49. Ji YC, Cai XN, Xu HQ, Li HS, Xiao Y, Li Y,. Preliminary study on propranolol treatment in infantile facial hemangiomas. J Shantou Univ Med Coll 2012; 25: 27-29.
50. Liang QS, Yu LZ,. The observation of propranolol treatment in infantile hemangiomas of proliferative phase. Chin J Med Guide 2012; 14: 1061-1062.
51. Leboulanger N, Fayoux P, Teissier N, Cox A, Van Den Abbeele T, Carrabin L, Couloigner V, Nicollas R, Triglia JM, Ayari S, Froehlich P, Lescanne E, Marianowski R, Mom T, Mondain M, Marie JP, Roger G, Garabédian EN, Denoyelle F,. Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: a preliminary retrospective study of French experience. Int J Pediatr Otorhinolaryngol 2010; 74: 1254-1257.
52. Mulliken JB, Fishman SJ, Burrows PE,. Vascular anomalies. Curr Probl Surg 2000; 37: 517-584.
53. Muir T, Kirsten M, Fourie P, Dippenaar N, Ionescu GO,. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations. Pediatr Surg Int 2004; 19: 766-773.
54. Tan ST, Itinteang T, Leadbitter P,. Low-dose propranolol for infantile haemangioma. J Plast Reconstr Aesthet Surg 2011; 64: 292-299.
55. Zarem HA, Edgerton MT,. Induced resolution of cavernous hemangiomas following prednisolone therapy. Plast Reconstr Surg 1967; 39: 76-83.
56. Boon LM, MacDonald DM, Mulliken JB,. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg 1999; 104: 1616-1623.
57. Buckmiller LM,. Propranolol treatment for infantile hemangiomas. Curr Opin Otolaryngol Head Neck Surg 2009; 17: 458-459.
58. Azzopardi S, Wright TC,. Novel strategies for managing infantile hemangiomas. Ann Plast Surg 2012; 68: 226-228.
59. D'Angelo G, Lee H, Weiner RI,. cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation. J Cell Biochem 1997; 67: 353-366.
60. Storch CH, Hoeger PH,. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 2010; 163: 269-274.
61. Truong MT, Perkins JA, Messner AH, Chang KW,. Propranolol for the treatment of airway hemangiomas: a case series and treatment algorithm. Int J Pediatr Otorhinolaryngol 2010; 74: 1043-1048.